Since KCa3.1 channel inhibition reduces the release of inflammatory cytokines and affects the function of inflammatory cells27–29, we tested the role of the Th2 response in the occurrence of intestinal disease in the CF mouse. This evidence concerns the gene KCNN4 and intestinal disorder.